Expedia Analysts Boost Their Forecasts After Upbeat Q2 Results

Expedia Group (EXPE) reported stronger-than-anticipated second-quarter results, with revenue of $3.79 billion, up 6% year-over-year, and EPS of $4.24, both exceeding consensus estimates. The company subsequently raised its full-year revenue guidance to $14.10 billion-$14.38 billion and issued Q3 revenue guidance above expectations, signaling robust performance. This positive outlook led to varied analyst reactions, including BofA Securities raising its price target to $240 while Piper Sandler, despite raising its target to $190, maintained an Underweight rating.

Analysis

Expedia Group reported a robust second quarter, exceeding consensus estimates on both revenue and earnings. The company posted revenue of $3.79 billion, a 6% year-over-year increase that surpassed the Street's $3.70 billion forecast, alongside earnings per share of $4.24, which beat the $3.90 estimate. This performance prompted management to raise its full-year revenue guidance to a new range of $14.10 billion to $14.38 billion, positioning the high end of the range significantly above the prior consensus of $14.15 billion. Furthermore, the third-quarter revenue projection of $4.22 billion to $4.30 billion also came in above expectations, indicating sustained operational momentum. Despite these strong fundamentals and positive outlook, analyst sentiment is notably divided. While BofA Securities reiterated a Buy rating and increased its price target substantially to $240 from $211, Piper Sandler maintained its Underweight rating, even while raising its price target to $190 from $135, suggesting underlying concerns may persist for some institutional observers.

Key Decisions for Investors

• Investors with a bullish thesis can find confirmation in the strong top-and-bottom-line beats, 6% YoY revenue growth, and upwardly revised full-year guidance, supporting the bull case articulated by BofA's $240 price target.
• Caution is warranted due to the significant divergence in analyst opinions; Piper Sandler's persistent Underweight rating, despite a price target increase, signals that underlying risks or valuation concerns may not be fully resolved by the positive quarterly results.
• Given the conflicting institutional views, it may be prudent to monitor for further analyst commentary that could clarify the discrepancy and to assess the company's ability to meet its new, higher guidance in the next reporting period before initiating or expanding a position.